Merit Medical Systems Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名12/206位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价103.00。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
Merit Medical Systems Inc评分
相关信息
行业排名
12 / 206
全市场排名
69 / 4562
所属行业
医疗设备与耗材
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
11
位分析师
买入
评级
103.000
目标均价
+23.93%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
Merit Medical Systems Inc亮点
亮点风险
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
公司代码MMSI
公司Merit Medical Systems Inc
CEOAronson (Martha Goldberg)
网址https://www.merit.com/
常见问题
Merit Medical Systems Inc(MMSI)的当前股价是多少?
Merit Medical Systems Inc(MMSI)的当前股价是 87.390。
Merit Medical Systems Inc的股票代码是什么?
Merit Medical Systems Inc的股票代码是MMSI。
Merit Medical Systems Inc股票的52周最高点是多少?
Merit Medical Systems Inc股票的52周最高点是111.450。
Merit Medical Systems Inc股票的52周最低点是多少?
Merit Medical Systems Inc股票的52周最低点是78.116。
Merit Medical Systems Inc的市值是多少?
Merit Medical Systems Inc的市值是5.18B。
Merit Medical Systems Inc的净利润是多少?
Merit Medical Systems Inc的净利润为120.36M。
现在Merit Medical Systems Inc(MMSI)的股票是买入、持有还是卖出?
根据分析师评级,Merit Medical Systems Inc(MMSI)的总体评级为买入,目标价格为103.000。
Merit Medical Systems Inc(MMSI)股票的每股收益(EPS TTM)是多少
Merit Medical Systems Inc(MMSI)股票的每股收益(EPS TTM)是2.008。